MicroRNAs role in telomere length maintenance and telomerase activity in tumor cells

被引:1
作者
Bortoletto, Stefanne [1 ]
Nunes-Souza, Emanuelle [1 ]
Marchi, Rafael [1 ]
Ruthes, Mayara Oliveira [1 ]
Okano, Larissa M. [1 ]
Tofolo, Maria Vitoria [1 ]
Centa, Ariana [2 ]
Fonseca, Aline S. [1 ]
Rosolen, Daiane [1 ]
Cavalli, Luciane R. [1 ,3 ]
机构
[1] Res Inst Pele Pequeno Principe, Fac Pequeno Principe, Curitiba, PR, Brazil
[2] Univ Alto Vale Rio Peixe Uniarp, Cacador, SC, Brazil
[3] Georgetown Univ, Lombardi Comprehens Canc Ctr, Oncol Dept, Washington, DC 20007 USA
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2024年 / 102卷 / 09期
关键词
Telomerase; Telomere; Telomere length; hTERT; miRNAs; Cancer; HEPATOCELLULAR-CARCINOMA; TARGETING HTERT; DOWN-REGULATION; MELANOMA-CELLS; BREAST-CANCER; PROLIFERATION; SENESCENCE; APOPTOSIS; PROTEIN; GROWTH;
D O I
10.1007/s00109-024-02467-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
MiRNAs, a class of non-coding RNA molecules, have emerged as critical modulators of telomere length and telomerase activity by finely tuning the expression of target genes (and not gene targets) within signaling pathways involved in telomere homeostasis. The primary objective of this systematic review was to compile and synthesize the existing body of knowledge on the role, association, and involvement of miRNAs in telomere length. Additionally, the review explored the regulation, function, and activation mechanism of the human telomerase reverse transcriptase (hTERT) gene and telomerase activity in tumor cells. A comprehensive analysis of 47 selected articles revealed 40 distinct miRNAs involved in these processes. These miRNAs were shown to exert their function, in both clinical cases and cell line models, either directly or indirectly, regulating hTERT and telomerase activity through distinct molecular mechanisms. The regulatory roles of these miRNAs significantly affected major cancer phenotypes, with outcomes largely dependent on the tissue type and the cellular actions within the tumor cells, whereby they functioned as oncogenes or tumor suppressors. These findings strongly support the pivotal role of miRNAs in modulating telomere length and telomerase activity, thereby contributing to the intricate and complex regulation of telomere homeostasis in tumor cells. Moreover, they emphasize the potential of targeting miRNAs and key regulatory genes as therapeutic strategies to disrupt cancer cell growth and promote senescence, offering promising avenues for novel cancer treatments.
引用
收藏
页码:1089 / 1100
页数:12
相关论文
共 96 条
  • [91] RETRACTED: Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition (Retracted Article)
    Zhang, Xue
    Bai, Jian
    Yin, Hang
    Long, Long
    Zheng, Zhewen
    Wang, Qingqing
    Chen, Fengxia
    Yu, Xiaoyan
    Zhou, Yunfeng
    [J]. MOLECULAR ONCOLOGY, 2020, 14 (10) : 2589 - 2608
  • [92] Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck
    Zhang, Yang
    Sturgis, Erich M.
    Huang, Zhigang
    Zafereo, Mark E.
    Wei, Qingyi
    Li, Guojun
    [J]. CANCER, 2012, 118 (02) : 485 - 492
  • [93] PITX1 plays essential functions in cancer
    Zhao, Jingpu
    Xu, Yongfeng
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [94] RETRACTION: MicroRNA-491-5p suppresses cervical cancer cell growth by targeting hTERT (Retraction of Vol 34, Pg 979, 2015)
    Zhao, Qiang
    Zhai, Ying-Xian
    Liu, Huan-Qiu
    Shi, Ying-Ai
    Li, Xin-Bai
    [J]. ONCOLOGY REPORTS, 2021, 46 (06)
  • [95] miR-1182 inhibits growth and mediates the chemosensitivity of bladder cancer by targeting hTERT
    Zhou, Jun
    Dai, Wenbin
    Song, Jianming
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 470 (02) : 445 - 452
  • [96] MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer
    Zhou, Na
    Fei, Dan
    Zong, Shan
    Zhang, Mingyue
    Yue, Ying
    [J]. ONCOLOGY LETTERS, 2016, 12 (05) : 3633 - 3639